International Journal of Obesity Supplements
Overview
International Journal of Obesity Supplements is a scientific journal, published since 2011 in English. The journal's country of origin is United Kingdom.
Details
Details
Abbr.
Int J Obes Suppl
Start
2011
End
2020
Frequency
Irregular
p-ISSN
2046-2166
e-ISSN
2046-2174
Country
United Kingdom
Language
English
Recent Articles
1.
Muscogiuri G, Tuccinardi D, Nicastro V, Barrea L, Colao A, Savastano S
Int J Obes Suppl
. 2020 Jul;
10(1):62-72.
PMID: 32714513
Growing evidence suggested that Sleep Disorders (SD) could increase the risk of developing obesity and could contribute to worsen obesity-related cardiovascular risk. Further, obesity has been reported to blunt sleep...
2.
Migliaccio S, Brasacchio C, Pivari F, Salzano C, Barrea L, Muscogiuri G, et al.
Int J Obes Suppl
. 2020 Jul;
10(1):50-61.
PMID: 32714512
Cardiovascular diseases (CVD) represent to date the leading cause of mortality in both genders in the developed countries. In this context, a strong need for CVD prevention is emerging through...
3.
Marzullo P, Di Renzo L, Pugliese G, De Siena M, Barrea L, Muscogiuri G, et al.
Int J Obes Suppl
. 2020 Jul;
10(1):35-49.
PMID: 32714511
The co-existence of humans and gut microbiota started millions of years ago. Until now, a balance gradually developed between gut bacteria and their hosts. It is now recognized that gut...
4.
Gambineri A, Conforti A, Di Nisio A, Laudisio D, Muscogiuri G, Barrea L, et al.
Int J Obes Suppl
. 2020 Jul;
10(1):27-34.
PMID: 32714510
Several human and animal studies have demonstrated that cardiometabolic parameters in infancy, childhood, adolescence and even adulthood are negatively influenced by many factors besides energy imbalance. Interestingly, maternal weight excess...
5.
Cataldi M, Cignarelli A, Giallauria F, Muscogiuri G, Barrea L, Savastano S, et al.
Int J Obes Suppl
. 2020 Jul;
10(1):14-26.
PMID: 32714509
Waiting for a definite answer from well-designed randomized prospective clinical trials, the impact of the new antiobesity drugs -liraglutide, bupropion/naltrexone, phentermine/topiramate and lorcaserin- on cardiovascular outcomes remains uncertain. What has...
6.
Barrea L, Annunziata G, Bordoni L, Muscogiuri G, Colao A, Savastano S
Int J Obes Suppl
. 2020 Jul;
10(1):1-13.
PMID: 32714508
Epidemiological data support the view that both obesity and cardiovascular diseases (CVD) account for a high proportion of total morbidity and mortality in adults throughout the world. Obesity and CVD...
7.
Gambineri A, Laudisio D, Marocco C, Radellini S, Colao A, Savastano S
Int J Obes Suppl
. 2019 Aug;
9(1):65-72.
PMID: 31391925
Obesity is associated with infertility in women through multiple and complex mechanisms. Briefly, the adipose tissue through the production of many factors, such as leptin, free fatty acids (FFA), and...
8.
Bellastella G, Menafra D, Puliani G, Colao A, Savastano S
Int J Obes Suppl
. 2019 Aug;
9(1):50-64.
PMID: 31391924
Obesity is considered a worldwide epidemic disease. Many pathological conditions have been associated to obesity but the evidence relating to impaired fertility in males with obesity are contrasting. The aim...
9.
Barrea L, Altieri B, Polese B, De Conno B, Muscogiuri G, Colao A, et al.
Int J Obes Suppl
. 2019 Aug;
9(1):32-49.
PMID: 31391923
Over the past 20 years the use of dietary supplements as adjuvant therapy for weight loss gained growing favor among consumers and dietician-nutritionists, with the subsequent astounding increase in health...
10.
Migliaccio S, Di Nisio A, Mele C, Scappaticcio L, Savastano S, Colao A
Int J Obes Suppl
. 2019 Aug;
9(1):20-31.
PMID: 31391922
Epidemiological studies reported that vitamin D deficiency represents an increasingly widespread phenomenon in various populations. Vitamin D deficiency is considered a clinical syndrome determined by low circulating levels of 25-hydroxyvitamin...